• Publications
  • Influence
Identification of differential expressed lncRNAs in human thyroid cancer by a genome‐wide analyses
The findings reveal that lots of lncRNAs are dysregulated and may play critical roles in thyroid cancer, and this study could provide useful resource for identification and investigation of novel lncRNA candidates for thyroid cancer.
Up-regulated long non-coding RNA DUXAP8 promotes cell growth through repressing Krüppel-like factor 2 expression in human hepatocellular carcinoma
It is revealed that down-regulation of lncRNA DUXAP8 inhibited HCC cells proliferation and colony formation ability and can provide a valuable resource of HCC-associated lncRNAs and new insights into the biological functions of l NCRNAs in HCC development.
The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism.
Application of Minimally Invasive Video-assisted Technique in Papillary Thyroid Microcarcinoma
MIVAT can be safely applied in PTMC patients with positive impact on patients outcome by comparable results to a conventional procedure after a median follow-up of 5 years, and is a better alternative therapeutic treatment for patients with PTMC.
Bilateral Areolar Approach Endoscopic Thyroidectomy for Low-risk Papillary Thyroid Carcinoma: A Review of 137 Cases in a Single Institute
BAA is feasible and safe for the treatment of low-risk PTC patients, with favorable cosmesis, and is an alternative therapeutic treatment for selected patients with low- risk PTC, however, oncologic safety of BAA thyroidectomy for P TC patients needs to be verified by a large comparative series and long-term follow-up.
Down-regulated expression of Rap 1 GAP predicts unfavorable prognosis in diffuse type gastric cancer and may be correlated with EMT
Down-regulated expression of Rap1 GTPase-activating protein (Rap1GAP) is present predominantly in diffuse type gastric cancer, not in intestinal type and is associated with poor prognosis in diffusetype gastriccancer.
LncRNA RP11-138J23.1 Contributes to Gastric Cancer Progression by Interacting With RNA-Binding Protein HuR
The essential role of RP11-138J23.1 in GC is highlighted, suggesting that RP11 -138J 23.1 might be a potent therapeutic target for patients with GC.